Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aoibhlinn O'Toole

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Clinical and Experimental Gastroenterology|March 2, 2016
Optimal management of collagenous colitis: a reviewAoibhlinn O'Toole
Current Gastroenterology Reports|July 23, 2014
Environmental triggers for IBDAoibhlinn O'Toole, Joshua Korzenik
Digestive Diseases and Sciences|October 29, 2013
Appropriateness of laboratory testing in inflammatory bowel disease inpatients: an opportunity to reduce unnecessary healthcare costsAoibhlinn O'Toole, Gavin C Harewood
Current Gastroenterology Reports|July 20, 2015
Optimizing Biologic Agents in Ulcerative Colitis and Crohn's DiseaseAoibhlinn O'Toole, Alan C Moss
Digestive Diseases and Sciences|June 14, 2015
Inflammatory Bowel Disease Increases Risk of Adverse Pregnancy Outcomes: A Meta-AnalysisAoibhlinn O'Toole, Ogochukwu Nwanne, Tracy Tomlinson
Digestive Diseases and Sciences|January 6, 2016
Inflammatory Bowel Disease Provoked by Etanercept: Report of 443 Possible Cases Combined from an IBD Referral Center and the FDAAoibhlinn O'Toole, Matthew Lucci, Joshua Korzenik
World Journal of Gastroenterology|March 23, 2022
"Role of exercise in preventing and restoring gut dysbiosis in patients with inflammatory bowel disease": A letter to the editorNeasa Mc Gettigan, Aoibhlinn O'Toole, Karen Boland
Inflammatory Bowel Diseases|May 5, 2022
Letter to the Editor in Response to "Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease"Neasa Mc Gettigan, Karen Boland, Aoibhlinn O'Toole
International Journal of Colorectal Disease|June 9, 2021
Visceral adiposity and inflammatory bowel diseaseCatherine R Rowan, John McManus, Karen Boland, et al.
European Journal of Gastroenterology & Hepatology|January 20, 2022
Lost in words? The readability of medication information sheets in commonly used medication in inflammatory bowel diseasesKerr Hilary, Moran Carthage, Rasol Jawad, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Gastroenterology|March 2, 2016
Optimal management of collagenous colitis: a reviewAoibhlinn O'Toole
Current Gastroenterology Reports|July 23, 2014
Environmental triggers for IBDAoibhlinn O'Toole, Joshua Korzenik
Digestive Diseases and Sciences|October 29, 2013
Appropriateness of laboratory testing in inflammatory bowel disease inpatients: an opportunity to reduce unnecessary healthcare costsAoibhlinn O'Toole, Gavin C Harewood
Current Gastroenterology Reports|July 20, 2015
Optimizing Biologic Agents in Ulcerative Colitis and Crohn's DiseaseAoibhlinn O'Toole, Alan C Moss
Digestive Diseases and Sciences|June 14, 2015
Inflammatory Bowel Disease Increases Risk of Adverse Pregnancy Outcomes: A Meta-AnalysisAoibhlinn O'Toole, Ogochukwu Nwanne, Tracy Tomlinson
Digestive Diseases and Sciences|January 6, 2016
Inflammatory Bowel Disease Provoked by Etanercept: Report of 443 Possible Cases Combined from an IBD Referral Center and the FDAAoibhlinn O'Toole, Matthew Lucci, Joshua Korzenik
World Journal of Gastroenterology|March 23, 2022
"Role of exercise in preventing and restoring gut dysbiosis in patients with inflammatory bowel disease": A letter to the editorNeasa Mc Gettigan, Aoibhlinn O'Toole, Karen Boland
Inflammatory Bowel Diseases|May 5, 2022
Letter to the Editor in Response to "Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease"Neasa Mc Gettigan, Karen Boland, Aoibhlinn O'Toole
International Journal of Colorectal Disease|June 9, 2021
Visceral adiposity and inflammatory bowel diseaseCatherine R Rowan, John McManus, Karen Boland, et al.
European Journal of Gastroenterology & Hepatology|January 20, 2022
Lost in words? The readability of medication information sheets in commonly used medication in inflammatory bowel diseasesKerr Hilary, Moran Carthage, Rasol Jawad, et al.
Pageof 3